Navigation Links
Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Date:10/15/2007

significant disability when compared to patients treated with interferon beta-1a. This difference was statistically significant in favor of the alemtuzumab patients with a p-value less than the pre-specified value (p=0.01646) assigned for the three-year analysis.

Results for the secondary endpoints support the findings seen in the co- primary endpoints. Full, detailed efficacy and safety data from the study are expected to be presented at the 60th Annual Meeting of the American Academy of Neurology next spring.

"These results demonstrate the durability of the previously reported effect of alemtuzumab for the treatment of multiple sclerosis that, by our analysis, exceeds any current marketed products and anything that we can see in development," said Richard A. Moscicki, MD, chief medical officer for Genzyme. "We are very impressed with the consistency of these data and feel that they continue to point to the strong likelihood of alemtuzumab being approved for MS patients."

Safety Data: No New Cases of ITP

A total of six patients have been diagnosed with ITP associated with Grade 3 or 4 thrombocytopenia in this trial and there have been no new cases of ITP reported in the past year in this study.

Common non-serious adverse events included infusion reactions in the alemtuzumab patients and flu-like symptoms in patients using interferon beta- 1a. Severe infections were infrequent in the alemtuzumab patients and were resolved with or without an intervention. The incidence of all thyroid adverse events, including Graves' disease, was less than expected compared to early reports in the literature on the use of alemtuzumab in MS.

Two Phase 3 studies have recently begun examining the safety and efficacy of alemtuzumab for the treatment of multiple sclerosis. Genzyme and Bayer Schering Pharma AG, Germany announced last month the start of the CARE-MS I trial (Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis), a randomized
'/>"/>

SOURCE Genzyme Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...
4. Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
5. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
6. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
7. Cobalis Expects to Report Phase III Top-Line Results in May
8. XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
9. Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntingtons Disease
10. UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
11. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 A lot of discussion ... methods for treating  certain illnesses, injuries, or conditions. As medical ... previous treatment methods with ones that they consider to be ... there is not one textbook method of treatment that stands ...
(Date:1/23/2015)... 23, 2015  A new analysis of Centers for Medicare ... data shows that 81 percent of seniors chose lower-cost ... discounts at certain pharmacies. The findings were released by ... are now the foundation of Medicare Part D," said ...
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... 2011 The U.S. Food and Drug Administration today ... implement during 2011 to improve the most common path ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Key actions include: ... innovative, lower-risk medical devices, Clarifying when clinical data ...
... Throughout the playoffs and championship game of Professional Football, ... play at winning TemporalScanner™ Temporal Artery Thermometers. Football fans ... announced on national radio broadcasts of pro football,s divisional ... win an Exergen TemporalScanner. The "Exergen ...
Cached Medicine Technology:FDA to Improve Most Common Review Path for Medical Devices 2Exergen 'Game Time Temperature' Contest Helps Football Fans Tackle Cold and Flu Season 2Exergen 'Game Time Temperature' Contest Helps Football Fans Tackle Cold and Flu Season 3
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... 2015 IsoComforter, Inc. has introduced the most ... IsoTube design to treat specific body parts and muscle groups. ... and easy to use patented cold therapy machine with the ... orthopedic and muscle injuries. IsoComforter has become the industry ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list ... policy . , Some types of vehicles cannot be covered ... released blog post to see if their vehicle qualifies for auto ... some of the cars that cannot be covered by a plan. ...
(Date:1/22/2015)... 2015 State Forestry Institute of Mecklenburg-Vorpommern ... with support from GEOSYSTEMS, a dedicated Hexagon Geospatial and ... leverage Hexagon Geospatial’s ERDAS APOLLO for cataloging, ... as point clouds and documents. This effort will enable ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... Baxano, Inc. today,announced the addition of Tony Recupero ... and Marketing. Mr. Recupero, a well known industry,executive, is ... to an impressive procedural growth and revenue ramp during ... announcement, Jeff Bleich, CEO and founder of Baxano,said, "Over ...
... issued study that found retail pharmacy workers are exposed ... airborne pharmaceutical agents needs further review -, DREXEL, ... statement today regarding serious concerns about efforts,by McKesson/Parata to ... face when they work in pharmacies using air,pressure driven ...
... Search engine for medical professionals honored for second ... the leading,search engine for medical professionals, today announced ... Association. SearchMedica was named Best,Directory or Search Engine., ... and in the last year we continued incorporating ...
... Health Care Heroes, HARRISBURG, Pa., Nov. 10 ... to build tomorrow,s health care,workforce by showcasing eight ... Week., "This special week helps put middle ... that will benefit millions of,Pennsylvanians," said Governor Rendell. ...
... Program to offer expansive list of benefits for 4D ... ... announced a new partnership with 4D Pharmacy Management Systems, Inc.,that will greatly ... The announcement was made today by Mark,Murray, President of the Grand Rapids, ...
... 10 Medicaid Health Plans of,America (MHPA), the ... plans, today joined the chorus of noted,organizations calling ... economic,stimulus package this session that includes additional funding ... Harry Reid and Mitch McConnell, Speaker,Nancy Pelosi and ...
Cached Medicine News:Health News:Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers 2Health News:Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers 3Health News:SearchMedica.com Earns 2008 WebAward: Best Directory or Search Engine 2Health News:SearchMedica.com Earns 2008 WebAward: Best Directory or Search Engine 3Health News:Governor Rendell Shines Health Careers Week Spotlight on 8 In-Demand Occupations 2Health News:Governor Rendell Shines Health Careers Week Spotlight on 8 In-Demand Occupations 3Health News:Meijer and Prescription Benefit Manager 4D Team Up to Create Innovative Prescription Insurance Program 2Health News:Meijer and Prescription Benefit Manager 4D Team Up to Create Innovative Prescription Insurance Program 3Health News:Medicaid Health Plans of America Urges Congress to Pass Economic Recovery Package This Session Featuring Additional Funding for Medicaid 2
Curved delicate 5 mm blades....
... tissue forceps "micro 2000", ... spring tension light-weight instruments ... handles, extremely light weight, ... handle, fatigueless working, easy ...
Mini blades....
Operating microscope with motorized zoom and variable focus up to 405 mm....
Medicine Products: